January 21st 2020EP. 1: An Overview of B-Cell Malignancies
January 21st 2020EP. 2: MCL and CLL: NCCN Guidelines and Treatment Options
January 21st 2020EP. 3: B-Cell Malignancies: Coverage, Access, and Cost
January 21st 2020EP. 4: Considering BTK Inhibition's Role in Treating CLL and MCL
January 21st 2020EP. 5: CLL and MCL: Factors in Selecting a BTK Inhibitor
January 21st 2020EP. 6: B-Cell Malignancies: Cost and Integration of Novel Therapy
January 21st 2020EP. 7: B-Cell Malignancies: Evolving Role of Payers and Providers
January 21st 2020EP. 8: Ongoing Challenges in the Management of B-Cell Malignancies
